Join the Beyfortus group to help and get support from people like you.
Beyfortus News
Nirsevimab Effective Against RSV-Linked Bronchiolitis Hospitalization
WEDNESDAY, July 10, 2024 – Nirsevimab therapy is effective for reducing the risk for hospitalization for respiratory syncytial virus (RSV)-associated bronchiolitis among infants, according to a...
Real World Data Shows RSV Shot Beyfortus Cut Infant Hospitalizations by 90%
FRIDAY, March 8, 2024 – Real-world data show that a shot that protects babies against RSV is 90% effective in keeping them out of the hospital. Those numbers outstrip what had been expected of...
Real World Data Shows RSV Shot Beyfortus Cut Infant Hospitalizations by 90%
FRIDAY, March 8, 2024 – Real-world data show that a shot that protects babies against RSV is 90% effective in keeping them out of the hospital. Those numbers outstrip what had been expected of...
Nirsevimab Effective for Preventing RSV-Linked Hospitalization
FRIDAY, March 8, 2024 – Receipt of a single dose of nirsevimab is effective for preventing respiratory syncytial virus (RSV)-associated hospitalization for infants, according to research published...
Nirsevimab Protects Infants Against RSV-Linked Hospitalization
THURSDAY, Dec. 28, 2023 – Nirsevimab is efficacious for preventing hospitalization for respiratory syncytial virus (RSV)-associated lower respiratory tract infection among infants, according to a...
In Response to Shortage, CDC, FDA Accelerate Release of RSV Shots for Infants
FRIDAY, Nov. 17, 2023 – More than 77,000 doses of Beyfortus, the long-acting monoclonal antibody designed to protect infants too young for vaccination against respiratory syncytial virus (RSV), were...
CDC to Release Infants' RSV Shots to Help Ease Shortage
THURSDAY, Nov. 16, 2023 – To address a continuing nationwide shortage, more than 77,000 doses of RSV shots for infants were released Thursday by the U.S. Centers for Disease Control and Prevention...
Shortage of RSV Vaccines for Infants Prompts CDC Alert
TUESDAY, Oct. 24, 2023 – Demand for a new shot that protects babies against respiratory syncytial virus (RSV) has outpaced supply, prompting U.S. health officials to recommend the doses be saved for...
Shortage of Shots That Protect Babies Against RSV Prompts CDC Alert
TUESDAY, Oct. 24, 2023 – Demand for a new shot that protects babies against respiratory syncytial virus (RSV) has outpaced supply, prompting U.S. health officials to recommend the doses be saved for...
CDC Warns of Rise in RSV Cases Among Young Children, Infants
WEDNESDAY, Sept. 6, 2023 – Doctors are seeing a spike in severe cases of respiratory syncytial virus (RSV) among young children in Florida and Georgia, U.S. health officials warned Tuesday. The...
FDA Approves RSV Vaccine, Abrysvo, for Pregnant Women to Help Shield Newborns
TUESDAY, Aug. 22, 2023 – Women may soon have a vaccine they can take during a pregnancy to help protect their newborn from respiratory syncytial virus (RSV), following U.S. Food and Drug...
Pediatricians' Group Urges That All Infants Get New RSV Shot
WEDNESDAY, Aug. 16, 2023 – All infants should receive the new long-acting preventive monoclonal antibody for respiratory syncytial virus (RSV), the nation's leading pediatrics group said. The...
Pediatricians' Group Urges That All Infants Get New RSV Shot
WEDNESDAY, Aug. 16, 2023 – All infants should receive the new long-acting preventive monoclonal antibody for respiratory syncytial virus (RSV), the nation’s leading pediatrics group said. The A...
Most Infants Hospitalized With RSV Were Otherwise Healthy, Study Finds
TUESDAY, Aug. 15, 2023 – As experts begin preparing for another season of viruses, they now know that even healthy infants with no underlying health issues are at risk for severe respiratory...
CDC Recommends RSV Shot for All Infants
FRIDAY, Aug. 4, 2023 – The U.S. Centers for Disease Control and Prevention on Thursday recommended that all infants under the age of 8 months be given a new antibody shot to help guard against severe ...
Ask a question
To post your own question to this support group, sign in or create an account.